Pharmaceutical Technology, September 2023

Excipients should be treated equally when it comes to quality management, risk assessment, and testing.

FDA is anticipating how AI may advance manufacturing and improve supply chain security.

Recent research and perspectives shed light on an opportunity to better connect risk and knowledge through improved integration of systems.

Tumour-infiltrating lymphocyte (TIL) therapies offer a new route to target cancer.

Coprocessed excipients save time and cost while improving performance in a widening array of dosage forms.

Modular facilities allow for a certain amount of flexibility and reconfiguration options.

A structured cleaning procedure is essential to ensure the effective cleaning of equipment.

The pandemic and shifting focus to more complex therapeutics are driving growth in the outsourced formulation development services market.

The ACT EU initiative aims to develop the European Union further as a competitive centre for innovative clinical research.

European vaccine manufacturing is being boosted with high level investments.

There are many promising trials in the pipeline that may bring big news for major therapeutic areas.

Audits and inspections both assure that requirements have been fulfilled and whether documented proof is available, says Siegfried Schmitt, vice president, Technical at Parexel.

Pharma's ability to continually reinvent itself will be critical in growing future business operations.

Waters Corporation’s XBridge Premier GTx BEH size exclusion chromatography (SEC) columns are designed to improve analysis while lowering the cost of gene therapies.

The ROSS line of Double Planetary Mixers are fully customized and engineered for efficient processing of medical-grade silicone formulations in a portable workstation.

Interpreting data and understanding the various components of biologic drug substance testing is an important skillset to know as a lab personnel.